Ozempic is a brand-name glucagon-like peptide-1 (GLP-1) medication approved by the U.S. Food and Drug Administration (FDA) to ...

Semaglutide is an injectable drug formulated for the treatment of type 2 diabetes, but it’s since become increasingly popular ...

Two groups of people in the UK could be eligible for an innovative weight loss treatment. Those who qualify may be able to ...

‘Game-changing’ oral drug has similar success rate to injections but also comes with potentially serious side-effects ...

With massive demand for the GLP-1 tablets as they are approved for use in the UK, Helen Coffey asks experts how they differ ...

A Wegovy trial found those taking the weight loss injections had a 20% cut in the risk of major heart problems including ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It’s administered with a tiny needle that punctures ...

Learn how the two forms of semaglutide compare in treating type 2 diabetes and supporting weight loss, plus their dosing details and potential side effects.

Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties from compounding the drug. Our FDA/Food, Drug & Device and ...

The UK has approved a once daily Wegovy semaglutide pill for weight loss, marking Europe’s first oral GLP-1 treatment. It ...

Indian pharma majors Sun Pharma, Dr Reddy's and Glenmark on Saturday announced the launch of their generic versions of ...